ST

STRATAGENE CORP

  • CIK: 0001108674
  • EIN: 33-0683641
  • Business address: 11011 N TORREY PINES ROAD, LA JOLLA, California, 92037

Information

  • Mailing address
    , , Delaware,
  • Phone
    N/A
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Filings
    N/A

About STRATAGENE CORP

STRATAGENE CORP (CIK: 0001108674) is an American company incorporated in the state of California. Head office is located at 11011 N TORREY PINES ROAD, LA JOLLA, California, 92037. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). STRATAGENE CORP is a public company and trade via Over-The-Counter (OTC).

Old names:

  • STRATAGENE HOLDING CORP from 2000-31-Oct to 2003-02-Oct

Ownership

Owner Filings Transaction Date Type of Owner
REED JOHN C 0001181561 Jun-06-2007 director
THUNE NELSON F 0001193644 Jun-06-2007 officer: Sr. VP of Operations
EIBL CARLTON J 0001212356 Jun-06-2007 director
Sorge Joseph A MD 0001292340 Jun-06-2007 director, 10 percent owner, officer: President, CEO Chairman of Bd
Manion Robert 0001292342 Jun-06-2007 director
Pouk John R 0001292344 Jun-06-2007 officer: Senior Vice President
Martin Steven Robert 0001328822 Jun-06-2007 officer: Vice President and CFO
Ellman Peter 0001354876 Jun-06-2007 director
Weber David A 0001323221 Mar-31-2005 officer: Sr. VP, Marketing
THOLEN J DAVID 0001193642 Jun-03-2004 director
DEAL MARY JOANNE 0001193643 Jun-03-2004 officer: Sr. VP, Hycor Biomedical
JONES REG P 0001193663 Jun-03-2004 officer: Senior Vice President & CFO
DAVOUDZADEH DAVID PHD 0001206596 Jun-03-2004 officer: VP, Hycor Biomedical
Roelofs Nicolas H PHD 0001292341 Jun-03-2004 officer: Chief Operating Officer
Sherman Ronni L 0001292343 Jun-03-2004 officer: Exec VP and Gen Counsel

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by STRATAGENE CORP

Filings Format Description Filed/Effective File/Film Number
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046618 ( Act) Size: 15 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046617 ( Act) Size: 19 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046616 ( Act) Size: 16 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046615 ( Act) Size: 11 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046614 ( Act) Size: 10 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046613 ( Act) Size: 9 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046611 ( Act) Size: 13 KB		 Jun-08-2007

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001104659-07-046609 ( Act) Size: 14 KB		 Jun-08-2007

8-K Document

Current report filing

Acc-no: 0001104659-07-046044 (34 Act) Size: 21 KB		 Jun-07-2007

000-50786

07906066
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0001104659-07-046040 (34 Act) Size: 21 KB		 Jun-07-2007

000-50786

07905725
25-NSE Document Acc-no: 0001354457-07-000167 (34 Act) Size: 3 KB Jun-06-2007

000-50786

07904194
8-K Document

Current report filing

Acc-no: 0001104659-07-043598 (34 Act) Size: 21 KB		 May-29-2007

000-50786

07884412
8-K Document

Current report filing

Acc-no: 0001157523-07-005214 (34 Act) Size: 19 KB		 May-15-2007

000-50786

07853201
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001157523-07-005215 (34 Act) Size: 19 KB		 May-15-2007

000-50786

07853164
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001104659-07-039930 (34 Act) Size: 876 KB		 May-15-2007

000-50786

07851611
DEFM14A Document

Definitive proxy statement relating to a merger,acquisition, or disposition

Acc-no: 0001104659-07-037801 (34 Act) Size: 1808 KB		 May-10-2007

000-50786

07834802
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001328822-07-000013 ( Act) Size: 9 KB		 May-02-2007

10-K/A Document

Amendment to Annual report pursuant to section 13 and 15(d)

Acc-no: 0001104659-07-032524 (34 Act) Size: 760 KB		 Apr-27-2007

000-50786

07796205
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001328822-07-000012 ( Act) Size: 4 KB		 Apr-26-2007

PREM14A Document

Preliminary proxy statement relating to a merger, acquisition, or disposition

Acc-no: 0001104659-07-030475 (34 Act) Size: 1773 KB		 Apr-23-2007

000-50786

07782312

Recent 20 filings. View all STRATAGENE CORP filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • STRATAGENE CORP overview
  • STRATAGENE CORP job
  • STRATAGENE CORP stock
  • STRATAGENE CORP ownership
  • STRATAGENE CORP CEO
  • STRATAGENE CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Lexeo Therapeutics, Inc.
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1674 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1768 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 3694 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3327 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2547 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3706 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2917 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3575 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2885 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by